What is the dose equivalency of Suboxone (buprenorphine/naloxone) 8-2 film to Suboxone (buprenorphine/naloxone) tablet?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The 8-2 mg Suboxone film is therapeutically equivalent to the 8-2 mg Suboxone tablet, allowing for a one-to-one conversion between the two formulations. This is based on the fact that both contain the same active ingredients: 8 mg of buprenorphine and 2 mg of naloxone, as indicated in a sample discharge prescription for a 3-day supply 1. The key differences lie in their physical properties and patient preferences rather than their therapeutic effects.

Key Points to Consider:

  • Both formulations are used for the treatment of opioid use disorder.
  • The choice between film and tablet may depend on patient preference, insurance coverage, or specific clinical considerations.
  • A study from the Annals of Emergency Medicine in 2020 1 supports the use of either formulation, with a sample prescription suggesting a dose of 2 tablets or films once daily in the morning, which can be adjusted to twice daily if necessary.
  • The main distinction between the two formulations is not in their medication content but in how they are administered and their physical characteristics, such as dissolution time and taste.
  • In clinical practice, the decision to use the film or tablet formulation of Suboxone should prioritize patient compliance and preference, given their therapeutic equivalence.

From the Research

Dose Equivalency of Suboxone 8-2 Film to Tablet

  • The provided studies do not directly address the dose equivalency of Suboxone 8-2 film to tablet 2, 3, 4, 5, 6.
  • The studies primarily compare the efficacy of buprenorphine and clonidine in opioid detoxification, with varying doses and administration methods 2, 3, 4, 5, 6.
  • There is no specific information on the dose equivalency of Suboxone 8-2 film to tablet in the provided studies.
  • The studies suggest that buprenorphine is effective in controlling withdrawal symptoms, but do not provide a direct comparison of film and tablet formulations 2, 3, 4, 5, 6.

Key Findings

  • Buprenorphine is superior to clonidine in alleviating subjective and objective opiate withdrawal symptoms 3.
  • Buprenorphine provides more effective early relief of withdrawal symptoms compared to clonidine 5.
  • Buprenorphine is as effective as clonidine in controlling withdrawal symptoms, with a greater percentage of patients detoxified by buprenorphine receiving maintenance treatment 6.
  • The studies do not provide information on the specific dose equivalency of Suboxone 8-2 film to tablet, and further research would be needed to determine this equivalency 2, 3, 4, 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.